Literature DB >> 2841543

Simultaneous production of natural human tumor necrosis factor-alpha, -beta and interferon-alpha from BALL-1 cells stimulated by HVJ.

S Fukuda1, S Ando, O Sanou, M Taniai, M Fujii, N Masaki, K Nakamura, O Ando, K Torigoe, T Sugimoto.   

Abstract

B-cell human lymphoblastoid cell line, BALL-1, produced interferon-alpha (IFN-alpha) and cytotoxic factors by the stimulation of hemagglutinating virus of Japan (HVJ). These cytotoxic factors were identified to be tumor necrosis factor-alpha (TNF-alpha) and tumor necrosis factor-beta (TNF-beta) on the basis of molecular level analysis. In the kinetic study, it was found that the maximum production of IFN-alpha was reached at 16-20 hr and that of TNF-alpha was at 10-16 hr after the stimulation by HVJ, whereas the maximum production of TNF-beta was at 40-50 hr, suggesting that the regulation of TNF-alpha and TNF-beta genes are different. These cytokines were purified by monoclonal antibody linked column chromatography, respectively. IFN-alpha was further separated into 9 subspecies on the basis of the difference of isoelectric point by FPLC chromatofocusing method. From the N-terminal amino acid sequence analyses of the 7 species of 9 subspecies, these subspecies were classified into 3 subtypes according to the Weissmann's notation. On the other hand, the amino acid sequence of the tryptic peptides of purified TNF-alpha and TNF-beta coincided well with the parts of the complete amino acid sequences which had been deduced from complementary DNA of TNF-alpha and TNF-beta of BALL-1 cell.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2841543

Source DB:  PubMed          Journal:  Lymphokine Res        ISSN: 0277-6766


  14 in total

Review 1.  Regulation of tumor necrosis factor production by monocyte-macrophages and lymphocytes.

Authors:  G Trinchieri
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

2.  Identification and purification of arginine deiminase that originated from Mycoplasma arginini.

Authors:  K Sugimura; S Fukuda; Y Wada; M Taniai; M Suzuki; T Kimura; T Ohno; K Yamamoto; I Azuma
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

3.  Relationship between a novel human cytotoxin (factor 2) produced by a B cell line (Karpas 160) and phorbol-myristate-acetate-associated cytotoxicity.

Authors:  J Ni; A Karpas
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

4.  Effects of interferon-alpha on serum hepatitis C virus in patients with chronic hepatitis C.

Authors:  M Shibata; T Kumada; M Yamada; S Nakano; T Kudo; T Morishima
Journal:  Dig Dis Sci       Date:  1993-04       Impact factor: 3.199

5.  Gamma interferon is produced by human natural killer cells but not T cells during Staphylococcus aureus stimulation.

Authors:  R Yoshihara; S Shiozawa; T Fujita; K Chihara
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

6.  Inhibitory versus stimulatory effects of natural human interferon-alpha on proliferation of lymphocyte subpopulations.

Authors:  V Holán; S Nakamura; J Minowada
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

7.  Effects of natural interferon alpha, natural tumor necrosis factor alpha and their combination on human mesothelioma xenografts in nude mice.

Authors:  T Ohnuma; L Szrajer; J F Holland; M Kurimoto; J Minowada
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

8.  Cholesteryl Pullulan Encapsulated TNF-α Nanoparticles Are an Effective Mucosal Vaccine Adjuvant against Influenza Virus.

Authors:  Daiki Nagatomo; Madoka Taniai; Harumi Ariyasu; Mutsuko Taniguchi; Miho Aga; Toshio Ariyasu; Tsunetaka Ohta; Shigeharu Fukuda
Journal:  Biomed Res Int       Date:  2015-09-01       Impact factor: 3.411

9.  Establishment of a human fibroblast cell line producing tumor necrosis factor alpha (KMST-6/TNF) and growth inhibitory effects of its conditioned medium on malignant cells in culture.

Authors:  K Fushimi; K Torigoe; H Yamauchi; S Furusako; M Kurimoto; M Namba
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-06       Impact factor: 2.723

10.  Low-dose oral interferon alpha as prophylaxis against viral respiratory illness: a double-blind, parallel controlled trial during an influenza pandemic year.

Authors:  Alayne L Bennett; David W Smith; Martin J Cummins; Peter A Jacoby; Joseph M Cummins; Manfred W Beilharz
Journal:  Influenza Other Respir Viruses       Date:  2013-02-09       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.